CDRH Sets Date To Examine Patient-Focused Device Labeling Policies
This article was originally published in The Gray Sheet
Executive Summary
The device center will convene a meeting at FDA headquarters in September to discuss all facets of device patient labeling.
You may also be interested in...
Home-Use E-Labeling Pilot Round 2: CDRH Seeks Volunteers
FDA’s device center issued a request to participate for a pilot asking companies to electronically submit labeling for home-use devices to help develop a label database. This is the agency’s second go at such a pilot but the submissions process appears to be simplified this time around.
Standardized Device Labeling? CDRH Studies Practitioner Perceptions
The format of device labeling is controlled by the individual manufacturer, but CDRH is exploring whether health care practitioners can more easily find information from a more standardized device label template that includes a short-summary section. Industry advocates are skeptical that broad-scale standardization is feasible due to the diversity of devices and device users, but companies are assisting in the center’s plans to perform a cognitive study of clinicians this summer.
FDA Twitter Guidance Lacks Flexibility, And May Be Unconstitutional, Critics Say
Stakeholders say the agency’s communication requirements for space-limited online platforms are too restricting and violate the First Amendment. Many of them are calling on the agency to withdraw the guidance and try again. The device industry has a comparatively toned down response so far, but wants more flexibility.